Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aspira Pathlab & Diagnostics has informed the stock exchange that its trading window for dealing in company securities will be closed starting April 1, 2026. The window closure applies to all Directors, Connected Persons, and Designated Persons of the company. This is a routine compliance measure under SEBI's Insider Trading Regulations, triggered by the upcoming declaration of Audited Standalone Financial Results for the quarter and year ended March 31, 2026. The trading window will reopen 48 hours after the financial results are announced. The exact date of the Board Meeting to approve the results will be communicated separately under SEBI LODR regulations.
This is a standard regulatory filing and not an event-driven announcement. It signals that audited Q4 and FY26 results are forthcoming, but the window closure itself has no direct impact on shareholders or stock price. Insiders being barred from trading during this period is a routine governance practice.